Drugs
Melanoma researchers at Generex Biotechnology Corporation have made significant strides in cancer vaccine development, publishing a pivotal paper in the Journal of Immunotherapy. The study, led by scientist Nikoletta Kallinteris, showcases a novel melanoma vaccine concept that harnesses the power of T helper cells to stimulate the immune system. This
Drugs
A new study has found that combining a cancer vaccine with hormone-deprivation therapy can help patients with recurring prostate cancer. The clinical trial, led by scientists at the National Cancer Institute (NCI), was conducted to treat patients with nonmetastatic prostate cancer who were experiencing rising levels of prostate-specific antigen (PSA)
Drugs
Nitric oxide synthase II has been identified as a potential therapeutic agent for cancer treatment due to its ability to repel metastasis despite promoting angiogenesis. Researchers at the University of Texas MD Anderson Cancer Center have developed a gene therapy approach using adenoviral vectors to deliver the NOS II gene
Drugs
The New England Journal of Medicine recently published results from a pivotal phase III study demonstrating that Tarceva (erlotinib) improves survival in patients with advanced non-small cell lung cancer (NSCLC). The study, conducted by the U.S. National Cancer Institute of Canada Clinical Trials Group, involved 86 sites from 17
Drugs
Telik, Inc. announced positive interim data from two ongoing phase 2 clinical studies evaluating Telcyta in combination with standard chemotherapy for the treatment of advanced non-small cell lung cancer. The data were presented at the Eleventh World Conference on Lung Cancer in Barcelona, Spain. One trial evaluated the combination of
Drugs
Recent research in the United States and Japan has led to significant breakthroughs in cancer therapy, with study results highlighting the effectiveness of PTEN gene therapy in treating prostate cancer, as well as the antitumor activity of ZD6474 in lung adenocarcinoma cell lines. The studies, published in Cancer Detection and
Drugs
The American Association for Cancer Research (AACR) firmly believes that stem cell research, including research involving human embryonic stem cells, is crucial for advancing cancer research. AACR's position statement emphasizes the importance of continued experimentation with human stem cells to improve the evaluation of anticancer drugs, identify markers
Drugs
Astex, a fragment-based drug discovery and development company, has achieved a significant milestone with the approval of its Investigational New Drug (IND) application for the clinical development of its proprietary cell cycle inhibitor, AT7519, for the treatment of cancer. This approval marks a major breakthrough for Astex, allowing the company
Drugs
Researchers from the Institute of Cancer Research in England have discovered two novel small molecule inhibitors that can knock down hypoxia-related tumorigenesis. The inhibitors, NSC-134754 and NSC-643735, were identified through a high-throughput screen of 2,000 compounds and were shown to target hypoxia-inducible factor-1 (HIF-1) activity and protein induced by
Drugs
Clinical trials for Onyvax-P, a new immunotherapy, have revealed encouraging results in delaying the progression of hormone-resistant prostate cancer (HRPC) in patients. A paper published in Clinical Cancer Research confirms that the treatment, administered to patients with rising PSA levels, demonstrated a statistically significant decrease in PSA velocity and a
Drugs
BioLineRx has signed in-license agreements to develop and commercialize two new therapeutic candidates, BL-2030 and BL-2040, for the treatment of prostate cancer and metabolic syndrome, respectively. The company has obtained a worldwide exclusive license for the development of both compounds from BioRap Technologies and Yeda Research and Development Company, Ltd.
Drugs
Recent studies published in top immunology journals have provided significant insights into cancer vaccine development, highlighting the potential of new approaches to combat this disease. Researchers in Italy, the United States, and Germany have made strides in understanding the workings of cancer vaccines, including the use of dendritic cells and
